Commercial Implications
What If AI Visibility Doesn't Matter Yet?
AI discovery is immature, so waiting can look like the safe choice. But waiting is a forecast too, especially where buyers research privately before making contact.
AI-mediated discovery is uneven, hard to measure and split across platforms that keep changing. It is also already part of how some high-value buyers research, often before the business they’re evaluating knows an opportunity exists. Waiting only looks like the low-risk option if you assume you’ll see AI become commercially relevant before your position in it matters. Where buyers research privately, that assumption is hard to defend.
The Case for Waiting Is Stronger Than the AI Industry Admits
Gartner reported in January 2026 that 51% of one U.S. consumer sample said generative AI had changed how they research. In a separate sample, only about a third considered chatbots as effective as search engines for learning new information. Behavior is shifting faster than trust.
The buying data says the same. In Gartner surveys published in May 2026, willingness to let AI make a purchase decision topped out at 11% across the categories tested. Among consumers who had used AI while shopping for a recent purchase, 54% said they had to double-check all the information it provided. The samples are small and consumer-only, but the pattern looks like assisted research rather than delegated decision-making.
AI’s commercial influence is also difficult to isolate in analytics, which is why visibility and business outcomes have to be kept apart. Models change between releases. No platform has become the gatekeeper Google became. And much of what’s sold as AI visibility runs ahead of the evidence.
On that evidence, declining to fund a major program is defensible. The question is whether it’s the right evidence.
Immature Does Not Mean Irrelevant
Behavior shifting faster than trust is exactly the point. You don’t have to trust AI enough to let it make the purchase for it to influence what you research next.
The mistake is treating market maturity as the threshold for commercial relevance.
For an enterprise buyer, AI doesn’t need to award the contract. It only needs to influence which eight vendors become five. For someone buying a $20 million property, it doesn’t need to choose the agent. It only needs to influence which three names get researched further.
That research is already happening. In a survey of 350 B2B buyers published by Responsive in October 2025, 48% of U.S. buyers said they use generative AI for vendor discovery. Ardent Partners and Ivalua reported in July 2026 that about one in five procurement organizations already apply AI to supplier discovery and onboarding. Neither shows AI deciding who receives an RFP. Both place it in the research that comes before one.
So ask the question directly. How certain are you that procurement teams aren’t already using AI before deciding who deserves an RFP? How certain are you that family offices, wealth advisers and high-net-worth buyers aren’t using it before deciding which agents deserve a call?
Most companies measure observable demand: visits, inquiries, meetings, RFP invitations. Consideration increasingly forms before any of that is recorded. If high-value buyers do meaningful research before contacting a vendor, and AI is entering that research, conventional attribution cannot tell you every time AI influenced who reached consideration.
You can’t measure the opportunity you were never included in.
This isn’t only theoretical. In our own client work, we’ve seen inquiries that began through AI-assisted discovery while the wider channel was still immature. Our 90-day case study shows that AI visibility can move materially across buyer-led questions and competitive positions, even while the commercial effects remain difficult to attribute directly.
What Waiting Assumes
Waiting for clearer evidence rests on three forecasts: that AI won’t become commercially relevant before the signal is obvious, that you’ll recognize the signal when it comes, and that whatever needs fixing can be fixed quickly once it does. The first is already in question. The other two are no safer.
Tools can be bought later. Other work doesn’t compress. Getting departments to describe the same service consistently, or assembling the proof behind an important claim, takes time. Neither speeds up when a board suddenly decides AI matters.
Then there’s the recognition problem. The measurement limitations that make AI visibility hard to justify today are the same ones you’d rely on to tell you the market has matured. Worse, some of AI’s influence operates at a stage that produces no event at all: a vendor never researched further, an agent never called. Waiting for observable downstream proof before investigating upstream influence may itself be a risky decision rule.
Market Timing and Readiness Are Separate Decisions
The case for waiting treats two decisions as one. The first is about the market: is AI-mediated discovery important and measurable enough to justify real spending? The second is about the company: do we know how we’re represented, and could we respond if that changed?
A company can answer no to the first and still take the second seriously.
A company can decide it is too early to scale AI visibility without deciding it is too early to understand its position.
For a company competing for high-value contracts, understanding its position isn’t a quick check of what ChatGPT says. It’s a decision about whether to invest in understanding a part of the buying process that may be changing outside its existing measurement systems. Is AI influencing your buyers’ journey, and at which stage? Are you present when buyers start with the problem rather than your name? Which competitors appear instead, given that no business is represented in isolation?
An AI answer built from an outdated directory listing, old press coverage and a website that never explains what the company does now exposes contradictions that were there all along. The AI didn’t create the weakness. It made it visible. In our work, the problems this exposes have often been worth fixing independently of AI adoption.
Work That Survives the Bet
Under uncertainty, ask of any investment how much of its value depends on one particular future arriving.
Optimizing for how one model picks citations today is a bet that it won’t change. Buying a large technology stack because AI search is supposedly the next Google is a bet on platform dominance. Some of these will pay off. Many are premature.
Other work doesn’t need the forecast. Evidence that backs your important claims is useful to whoever, or whatever, is reading. So is fixing the three different ways your website, directory profiles and sales materials describe the same service. This is work on the company’s information and evidence infrastructure, including architecture that can be extended rather than rebuilt. It retains much of its value whether AI discovery accelerates, gets absorbed into search, moves to new platforms or grows slowly.
The third kind of investment is the easiest to miss: spending to find out. Not to “do AI visibility,” but to learn whether AI is already shaping your market, where, and against whom. That changes the economics. A six-figure investigation in a market where single contracts are worth millions doesn’t need to justify itself as a lead-generation campaign. It needs to justify itself as information supporting much larger commercial decisions.
Some investments are bets. Others survive the bet. The less certain the market, the more it pays to favor investments that reduce your dependence on predicting it correctly.
First-Mover Advantage Is a Weak Reason to Act
One argument for acting now we’d reject: move early and competitors will never catch up.
We’ve argued that in an immature channel, clear representation can win visibility out of proportion to underlying proof. We also expect that edge to narrow as competitors adapt and today’s tactics become standard practice. That’s a hypothesis, and it favors the skeptic.
If the case for acting now depends on a permanent first-mover advantage, the case is too weak. The argument here doesn’t need one.
The Risk of Waiting Is Not Symmetrical
The choice isn’t between a major AI visibility program and doing nothing. Investigating, building durable readiness and speculative execution are different decisions with different risks.
Consider the two ways to be wrong. A company that investigates and makes selective, durable improvements, only to see adoption develop slowly, keeps most of what it built: better information, stronger evidence, a clearer view of its competitors. A company that does nothing, and finds AI-assisted research mattered sooner than expected, may discover weak representation, fragmented proof, better-represented competitors, no baseline to measure change against, and buying decisions that were forming before it could see them.
Neither is a catastrophe. But only one depends on forecasting correctly that there will be enough warning, and enough time.
A company that investigates and concludes further investment is premature has bought information. A company that doesn’t has kept the capital and kept the uncertainty.
Some companies will weigh that and still choose to wait. If they’ve looked, that’s a decision. If nobody looked, it’s a forecast nobody examined.
Whether AI visibility matters to a particular business at all, given its customers and how they buy, is a separate question.
How Certain Are You?
You may be waiting for clearer evidence that AI matters to your buyers. What would that evidence actually look like?
If AI helps someone find you, an inquiry may eventually appear. If it helps a procurement team exclude you before an RFP, or a family office decide another adviser deserves the call, there may be nothing in your analytics at all.
A company doesn’t need to believe AI will replace search to justify investigating that possibility. It needs to decide whether the buying decisions at stake are valuable enough to justify reducing uncertainty before they become easier to observe.
Doing nothing is a forecast too. It assumes you’ll know the market has changed soon enough to respond.
And how certain are you that the competitors you are waiting alongside are actually waiting?
How certain are you that you will know soon enough?
Questions
Frequently asked questions
Is it reasonable to hold off on AI visibility investment until the market matures?
For large, platform-specific programs, often yes. Holding off on finding out whether AI is already shaping your buyers' research is harder to justify. Some of that influence happens where your analytics can't see it, so the signal you're waiting for may arrive after it mattered.
How can you tell whether an AI visibility investment is a bet?
Ask what it would be worth if the leading AI platform changed how it picks sources next year. If most of the value disappears, it's a bet. That doesn't rule it out. It should be sized like one.
What signs would suggest it's time to invest more in AI visibility?
Watch for buyers mentioning AI tools when they explain how they found you, competitors consistently appearing in AI answers to your buyers' core questions, and your own measurement starting to capture AI-influenced journeys. Look outside your data too. If trade publications, buyer-side media, procurement publications or relevant industry conferences start treating AI-assisted research, sourcing or vendor discovery as normal behavior, that is another signal the buying environment is changing. Don't rely only on evidence that requires a buyer to reach you. Exclusion rarely leaves one.
